Explore our resources by research/diagnostic specialty or content type
ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.
The ALPCO Glucagon ELISA is for the quantitative determination of glucagon in human EDTA plasma. This assay was developed for ease-of-use and demonstrates superior sensitivity while eliminating cross-reactivity issues present in other commercially-available assays.
ALPCO’s Active GLP-1 (7-36) amide Chemiluminescence ELISA accurately measures the major biologically active circulating form of GLP-1.1,2 This well-characterized assay provides high analytical sensitivity, a short incubation time, and measures active GLP-1 (7-36) amide in fasted and fed samples.
The STELLUX® Rodent Insulin ELISA provides the flexibility to run both mouse and rat samples on the same plate with minimal to no dilution and a short two hour incubation.
ALPCO’s Insulin Chemiluminescence ELISA detects insulin at levels as low as 20 pg/mL in human serum, plasma, and β-islet tissue culture supernatants, without cross-reactivity to human intact proinsulin, mouse insulin, or rat insulin.
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts?
The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50+ unique molecular allergens. Because molecular allergens can be precisely replicated with very high purity, th...
Reduce False Positives from 26% to 7%! An increase in clinical specificity, and a decrease in false positives, enables clinicians to better evaluate IBD/IBS patients. Clinicians can schedule follow-up colonoscopies for the patients that need it most and start IBS patients on the right treatment path.
For laboratories with a compatible clinical chemistry analyzer, upgrading to the calprotectin immunoturbidimetric assay can improve efficiency and generate additional capacity. Laboratories can potentially eliminate a CLIA system or simply create new capacity on that system by transferring calprotectin to another analyzer.
Test results from outside laboratories can sometimes take up to 5 days. Random access testing enables laboratories to offer affordable same-day results. On-site testing eliminates the shipping process and maintains remnant samples on-site.